Literature DB >> 6683657

Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats.

L P Dwoskin, B S Neal, S B Sparber.   

Abstract

The involvement of alpha 2-noradrenergic receptors in the expression of opiate withdrawal was studied using an operant behavioral model of acute morphine dependence. Clonidine, an alpha 2-agonist, attenuated and yohimbine, an alpha 2-antagonist, exacerbated the naloxone-induced suppression of fixed ratio 15 responding in rats pretreated several hours earlier with a single, moderate dose of morphine. These data indicate that the alpha 2-agonist action of clonidine is responsible for its amelioration of withdrawal symptoms. It also validates the acute dependence model for studying the pharmacology of opiates and associated adaptive processes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6683657     DOI: 10.1016/0014-2999(83)90248-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Effect of chronic morphine treatment on alpha(2)-adrenoceptor mediated autoinhibition of transmitter release from sympathetic varicosities of the mouse vas deferens.

Authors:  S Karunanithi; N A Lavidis
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents.

Authors:  L Morales; C Perez-Garcia; L F Alguacil
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 3.  Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

4.  Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats.

Authors:  J R Taylor; V O Lewis; J D Elsworth; P Pivirotto; R H Roth; D E Redmond
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  The serotonin2 antagonist ritanserin blocks quasi-morphine withdrawal at a time when mianserin is no longer effective.

Authors:  B S Neal; S B Sparber
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Modification of quasi-morphine withdrawal with serotonin agonists and antagonists: evidence for a role of serotonin in the expression of opiate withdrawal.

Authors:  M S Kleven; S B Sparber
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Long-term effects of neonatal exposure to isobutylmethylxanthine. II. Attenuation of acute morphine withdrawal in mature rats.

Authors:  B S Neal; R B Messing; S B Sparber
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Effects of alpha 2-agonists on morphine withdrawal behaviour: potentiation of jumping mediated by alpha 2-receptors.

Authors:  J W van der Laan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

9.  Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

10.  Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures.

Authors:  Andrew C Harris; Stephanie L Hanes; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2004-05-26       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.